Lidocaine-Prilocaine (EMLA) Cream as Analgesia in Hysteroscopy Practice
NCT ID: NCT01094015
Last Updated: 2010-04-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
92 participants
INTERVENTIONAL
2007-07-31
2009-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Lidocaine-Prilocaine (EMLA) Cream as Analgesia in Hysterosalpingography Practice
NCT01303614
Pertubation With Lignocaine in Endometriosis
NCT01329796
Effect of Alcohol Sclerotherapy on Pelvic Pain and Quality of Life in Women With Ovarian Endometriosis
NCT06955221
Intracervical Block Versus Placebo to Assess Pain Control During Hysterosalpingogram
NCT00372658
Clinical Trial the Use of Levonorgestrel-releasing Intrauterine System Versus Etonogestrel Implant in Endometriosis
NCT02480647
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lidocaine-Prilocaine cream
lidocaine-prilocaine cream
Implementation of 3 cm of lidocaine-prilocaine in the endocervical canal, 10 minutes before the intervention with a syringe without needle 5ml. Application, with a swab of the anesthetic cream ectocervix level.
placebo
gel application for the transmission of ultrasound
3 cm of gel application for the transmission of ultrasound into the endocervical canal 10 minutes before surgery, with a 5ml syringe without needle. Application, with a swab in gel ectocervix
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
lidocaine-prilocaine cream
Implementation of 3 cm of lidocaine-prilocaine in the endocervical canal, 10 minutes before the intervention with a syringe without needle 5ml. Application, with a swab of the anesthetic cream ectocervix level.
gel application for the transmission of ultrasound
3 cm of gel application for the transmission of ultrasound into the endocervical canal 10 minutes before surgery, with a 5ml syringe without needle. Application, with a swab in gel ectocervix
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* acceptance to participate in the study signed informed consent
Exclusion Criteria
* refusal of the patient
* patients under age 18 and pregnant
* dropout
* unbearable pain that involves other analgesic measures
* allergic reactions to topical anesthetics
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Consorci Sanitari de Terrassa
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Department of Gynecology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Baldomero Arnau, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Consorci Sanitari de Terrassa
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Consorci Sanitari de Terrassa
Terrassa, Barcelona, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HISTEROS-07
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.